| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/23/2008 | CN101108227A Konjak extractive powder capsule |
| 01/23/2008 | CN101108211A Medicament for treating hemiplegia and method of preparing the same |
| 01/23/2008 | CN101108198A Epimedium erigeron pharmaceutical composition |
| 01/23/2008 | CN101108196A Method of producing glossy ganoderma polypeptide product |
| 01/23/2008 | CN101108193A Water-solubility rutoside and method of manufacturing the same and oral preparation |
| 01/23/2008 | CN101108181A Method of extracting flavone substance and ellagic acid from pomegranate blossom |
| 01/23/2008 | CN101108000A Addition-application method of functional properties fat planting food mixture |
| 01/23/2008 | CN101107992A Braized three mushrooms |
| 01/23/2008 | CN100363377C N heterocyclic substituted adenosine derivatives |
| 01/23/2008 | CN100363363C Novel quinuclidine derivatives and medicinal compositions containing the same |
| 01/23/2008 | CN100363362C Thiazole derivatives as NPY receptor antagonists |
| 01/23/2008 | CN100363052C Heart nourishing palpitation stabilizing granules and its preparation method |
| 01/23/2008 | CN100363048C Quality control method for pile eliminating tablet |
| 01/23/2008 | CN100363039C Method for treating hypertension disease |
| 01/23/2008 | CN100363010C Compound injection composed of borneol and wilsonii extract and its preparing method |
| 01/23/2008 | CN100363008C Method for preparing alprostadil liposome |
| 01/23/2008 | CN100362993C Tanshinone emulsion and its making method |
| 01/23/2008 | CN100362985C Chinese medicine capsules for treating coronary heart disease and hyperlipidemia and production thereof |
| 01/22/2008 | US7320991 Analogs of thalidomide as potential angiogenesis inhibitors |
| 01/22/2008 | US7320982 Use of 4-substituted tetrahydropyridines for the manufacture of medicaments acting upon TGF-β 1 |
| 01/22/2008 | US7320972 Hypercholesterolemia, cholesterol-associated benign and malignant tumors; hyperlipidemia, arteriosclerosis, and sitosterolemia; 6) (3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(2',3',4'-trimethoxybiphenyl-4-yl)azetidin-2-one |
| 01/22/2008 | US7320964 Modulation of expression of STAT-1 dependent genes |
| 01/22/2008 | US7320959 Transgenic aniomal nmodels; screening; administering peptide |
| 01/22/2008 | US7320872 Genetically engineered nervous system cells for use in the treatment of alzheimer's, parkinson's, amyotrophic lateral sclerosis, multiple sclerosis, trauma, brain, muscle, cardiovascular, vision , liver, kidney and pancreas disorders |
| 01/22/2008 | US7320803 Free from water of crystallization; use in foods, animal feeds, or in food supplements |
| 01/22/2008 | US7320786 Administering lyposomes of photosensitive receptors or ligands targeted to specific tissues, exposure to light causing destruction of bound tissues; treatment of eye neovascular disease due to macular degeneration, diabetes |
| 01/22/2008 | US7320679 Therapeutic use of growth factor, and delivery device, especially for the treatment of intimal hyperplasia |
| 01/22/2008 | CA2495967C New synthesis process and new crystalline form for agomelatine, and pharmaceutical compositions containing it |
| 01/22/2008 | CA2404120C Use of bradycardiac agents in the treatment of myocardial diseases accompanied by hypertrophy and new drug combinations |
| 01/22/2008 | CA2392168C Vitamin d analogues |
| 01/22/2008 | CA2368348C Biodegradable, injectable oligomer-polymer composition |
| 01/22/2008 | CA2333322C Nitric oxide synthase inhibitors |
| 01/22/2008 | CA2305807C Substituted fused heterocyclic compounds |
| 01/17/2008 | WO2008008375A2 Triazolyl pyridyl benzenesulfonamides as ccr2 or ccr9 modulators for the treatment of inflammation |
| 01/17/2008 | WO2008008359A2 Benzofuro-and benzothienopyryimidine modulators of the histamine h4 receptor |
| 01/17/2008 | WO2008008022A1 Isoindoline derivatives for the treatment of arrhythmias |
| 01/17/2008 | WO2008007835A1 2,4-quinazoline derivatives having activity to t-type calcium channel and preparation method thereof |
| 01/17/2008 | WO2008007654A1 Prophylactic and/or therapeutic agent for aneurysm |
| 01/17/2008 | WO2008007210A2 Nitrogenous n-substituted 4-spiro-heterocyclic 2, 2 -dimethylchromane derivatives |
| 01/17/2008 | WO2008006702A1 11beta-hydroxysteroid dehydrogenase type 1 active compounds |
| 01/17/2008 | WO2008006607A2 Pharmaceutical and nutraceutical products comprising vitamin k2 |
| 01/17/2008 | WO2008006583A1 Pyrimidine derivatives as alk-5 inhibitors |
| 01/17/2008 | WO2008006319A1 BIBENZIMIDAZOLE DERIVATIVES HAVING PPARγ AGONIST ACTIVITY AND THEIR USES |
| 01/17/2008 | WO2008006257A1 2,4,5-trisubstituted thiazole compounds,preparation methods, pharmaceutical compositions and medical uses thereof |
| 01/17/2008 | WO2008006168A1 Treatment of excessive neovascularization |
| 01/17/2008 | WO2007014051A3 Use of amylin and amylin agonists as cardioprotective or myoprotective agents |
| 01/17/2008 | WO2003004615A3 Secreted proteins |
| 01/17/2008 | US20080015255 Pharmaceutical Compositions Based on Fluorinated Sulphamides and Sulphinimides |
| 01/17/2008 | US20080015251 Means and method for treating lipotoxicity and other metabolically related phenomena |
| 01/17/2008 | US20080015238 Cycloalkylmethoxy-substituted acetic acid derivatives, processes for their preparation and their use as pharmaceuticals |
| 01/17/2008 | US20080015237 New compounds i/418 |
| 01/17/2008 | US20080015234 Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 01/17/2008 | US20080015223 Pyrazole Derivatives as Modulators of the 5-Ht2a Serotonin Receptor Useful for the Treatment of Disorders Related Thereto |
| 01/17/2008 | US20080015220 Biphenyl-2-ylcarbamic acid 1-{7-[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]heptyl}piperidin-4-yl ester; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist; bronchodilator agent; pulmonary disorders, chronic obstructive pulmonary disease and asthma |
| 01/17/2008 | US20080015215 Diamine derivatives |
| 01/17/2008 | US20080015214 3-piperidin-4-yl-indole orl-1 receptor modulators |
| 01/17/2008 | US20080015209 Compounds for the treatment of metabolic disorders |
| 01/17/2008 | US20080015204 Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 01/17/2008 | US20080015200 Benzofuro- and benzothienopyrimidine modulators of the histamine H4 receptor |
| 01/17/2008 | US20080015199 Triazolone derivatives |
| 01/17/2008 | US20080015195 Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase |
| 01/17/2008 | US20080015185 N-heterocyclic inhibitors of tnf-alpha expression |
| 01/17/2008 | US20080015183 Substituted quinazolin-4-ylamine analogues |
| 01/17/2008 | US20080015181 Pharmaceutical Compositions Comprising Droxidopa |
| 01/17/2008 | US20080015176 such as dabigatran etexilate in children; congenital heart disease, shunt or catheter thrombosis, pulmonary embolism, stroke in pregnant girls; pediatrics |
| 01/17/2008 | US20080015175 Nontoxic; inhibition of interleukin-1 beta -converting enzyme |
| 01/17/2008 | US20080015174 Metabolic Disease Treatments |
| 01/17/2008 | US20080015172 Caspase inhibitors and uses thereof |
| 01/17/2008 | US20080015169 Amino-methyl substituted tetracycline compounds |
| 01/17/2008 | US20080015152 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive, eating and nervous system disorders |
| 01/17/2008 | US20080014585 Synergistic activation of regulatory elements by rel proteins and a steroid receptor |
| 01/17/2008 | US20080014291 Process for the Production of Multi-Component Mineral Substance Preparations |
| 01/17/2008 | US20080014270 Methods for improved lipid metabolism and basal metabolic rate with lactoferrin |
| 01/17/2008 | US20080014263 Amorphous eprosartan mesylate and process for the preparation thereof |
| 01/17/2008 | US20080014262 Rapidly disintegrating tablet containing polyvinyl alcohol |
| 01/17/2008 | US20080014252 Topical compositions with long lasting effect |
| 01/17/2008 | US20080014250 Bifunctionalized polysaccharides |
| 01/17/2008 | US20080014249 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 01/17/2008 | US20080014238 Implantable medical devices comprising semi-crystalline poly(easter-amide) |
| 01/17/2008 | US20080014228 Solid form |
| 01/17/2008 | US20080014227 Heterocyclic compounds based on n6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds |
| 01/17/2008 | US20080014197 Neutralizing human anti-igfr antibody |
| 01/17/2008 | US20080014189 Diaminotriazoles useful as inhibitors of protein kinases |
| 01/17/2008 | US20080011293 Stable Xylometazoline and Oxymetazoline Solution |
| 01/17/2008 | CA2657748A1 Pharmaceutical and nutraceutical products comprising vitamin k2 |
| 01/17/2008 | CA2657308A1 Treatment of excessive neovascularization |
| 01/17/2008 | CA2657227A1 Pyrimidine derivatives as alk-5 inhibitors |
| 01/17/2008 | CA2657151A1 Isoindoline derivatives for the treatment of arrhythmias |
| 01/17/2008 | CA2657078A1 11beta-hydroxysteroid dehydrogenase type 1 active compounds |
| 01/16/2008 | EP1878743A2 Urotensin-II agonists and antagonists |
| 01/16/2008 | EP1878734A1 Novel lactam compound |
| 01/16/2008 | EP1878733A1 Pyrimidine derivatives as ALK-5 inhibitors |
| 01/16/2008 | EP1878732A1 HIGHLY SELECTIVE Rho-KINASE INHIBITOR |
| 01/16/2008 | EP1878727A1 2-aminoquinazoline derivatives |
| 01/16/2008 | EP1878441A2 Complement pathway inhibitors binding to C5 and C5a without preventing the formation of C5b |
| 01/16/2008 | EP1878436A1 Method of regenerating or repairing damaged tissue by using adrenomedulin |
| 01/16/2008 | EP1878431A1 Medicinal agent for preventing progression of apoptotic and jugulating necrotic changes in the organism tissues |
| 01/16/2008 | EP1877378A2 Oxindole compounds and their uses as therapeutic agents |
| 01/16/2008 | EP1877373A2 Biphenylazetidinone cholesterol absorption inhibitors |
| 01/16/2008 | EP1877045A2 Methods of treating atherosclerosis |